Indian IT giant Tech Mahindra and StaTwig are deploying VaccineLedger to address supply chain issues that affect COVID-19 vaccine stocks and shelf life.
Blockchain company StaTwig tested the VaccineLedger solution in India and the USA back in 2019. The company recently partnered with Indian IT giant Tech Mahindra to roll out the solution as part of a coronavirus vaccination campaign around the world.
VaccineLedger’s goal is to increase the transparency of the vaccine supply chain. This will help predict and prevent expiration, counterfeiting, quality control and availability issues. The StaTwig solution supports the integration of smart contracts and IoT technology to identify expired vaccines and provide temperature control during transit.
In addition, the two companies have jointly developed several enterprise security modules for mobile and web applications designed to meet the varying requirements of manufacturers and governments in different jurisdictions.
In regions where COVID-19 vaccine remains in short supply, improving supply chain efficiency could help ensure that stocks are used quickly and to the maximum. Rajesh Dhuddu of Tech Mahindra commented on the collaboration and project goals:
“First of all, it is necessary to solve the problem of the loss of vital medicines, for example, vaccines. We must unite to find an effective solution. Our strategic partnership with StaTwig will provide supply chain stakeholders with a single application to improve supply chain traceability. This will not only ensure the safety and security of the vaccine supply, but will also help in meeting the complex regulatory requirements set by the authorities in different countries. ”
Recall that the Republic of San Marino recently approved the release of COVID-19 vaccination passports on the VeChainThor blockchain using eNFT. Passports can be verified within the EU and beyond.
